A blood test that detects GFAP during emergency transport could kick off effective treatment for these patients before they even get to the hospital, potentially reducing their brain damage from ...

If the novel factor XI inhibitor abelacimab reaches the market for patients with atrial fibrillation (AF) who require anticoagulation, it may not be necessary to interrupt treatment ahead of invasive ...

A rapid blood test could speed treatment for people who have suffered a stroke related to brain bleeding, a new study says. Stroke victims with brain bleeds have nearly seven times higher blood levels ...